References
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499.
- Han C, He X, Xia X, et al. Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2015;10(8):e0135233.
- Chang Y-J, Hwu C-M, Yeh C-C, et al. Effects of subacute hypothyroidism on metabolism and growth-related molecules. Molecules. 2014;19(8):11178–11195.
- Liu H, Shan Z, Li C, et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid. 2014;24(11):1642–1649.
- Collet T-H, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809.
- Singh S, Trivedi R, Singh K, et al. Diffusion tensor tractography in hypothyroidism and its correlation with memory function. J Neuroendocrinol. 2014;26(11):825–833.
- Collins D, Wilcox R, Nathan M, et al. Celiac disease and hypothyroidism. Am J Med. 2012;125(3):278–282.
- Duntas LH, Maillis A. Hypothyroidism and depression: salient aspects of pathogenesis and management. Minerva Endocrinol. 2013;38(4):365–377.
- Radhakrishnan R, Calvin S, Singh JK, et al. Thyroid dysfunction in major psychiatric disorders in a hospital based sample. Indian J Med Res. 2013;138(6):888–893.
- Pattanayak RD, Pattanayak S. Chronic manic episode associated with hypothyroidism due to Hashimoto's disease: a case report. J Neuropsychiatry Clin Neurosci. 2014;26(4):E27.
- Khemka D, Ali JA, Koch CA. Primary hypothyroidism associated with acute mania: case series and literature review. Exp Clin Endocrinol Diabetes. 2011;119(8):513–517.
- Druss BG, Marcus SC, Olfson M, et al. The most expensive medical conditions in America. Health Aff (Millwood). 2002;21(4):105–111.
- Schectman JM, Pawlson LG. The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care-setting. J Gen Intern Med. 1990;5(1):9–15.
- Katz M, Scherger J, Conard S, et al. Healthcare costs associated with switching from brand to generic levothyroxine. Am Health Drug Benefits. 2010;3(2):127–134.
- Ernst FR, Barr P, Elmor R, et al. The economic impact of levothyroxine dose adjustments: the CONTROL HE study. Clin Drug Investig. 2017;37(1):71–83.
- Hansen LG, Chang S. Health research data for the real world: the MarketScan databases; 2011 [accessed 2015 Oct 15]. Available from: http://truvenhealth.com/portals/0/assets/PH_11238_0612_TEMP_MarketScan_WP_FINAL.pdf.
- United States Department of Labor. Bureau of labor statistics data; 2017 [accessed 2017 Jun 5]. Available from: https://data.bls.gov/cgi-bin/dsrv.
- Lisotto C, Mainardi F, Maggioni F, et al. The comorbidity between migraine and hypothyroidism. J Headache Pain. 2013;14(S1):138.
- McElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry. 2004;65 (Suppl 15):35–44.
- Bunevicius R, Prange AJ. Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry. 2010;23(4):363–368.
- Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther. 2010;8(11):1559–1565.
- Schmidt-Ott UM, Ascheim DD. Thyroid hormone and heart failure. Curr Heart Fail Rep. 2006;3(3):114–119.
- Chaker L, Ligthart S, Korevaar TIM, et al. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med. 2016;14(1):150.
- Rizos C, Elisaf M, Liberopoulos E. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76–84.
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.
- Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics. 1999;16(1):1–8.
- Kamal-Bahl SJ, Pantely S, Pyenson B, et al. Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease. Prev Chronic Dis. 2006;3(3):1–10.
- D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993;32(5):382–387.
- Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
- Malehi AS, Pourmotahari F, Angali KA. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ Rev. 2015;5:11.
- Geue C, Lorgelly P, Lewsey J, et al. Hospital expenditure at the end-of-life: what are the impacts of health status and health risks? PLoS One. 2015;10(3):e0119035.
- Shafrin J. What is the negative binomial model? Healthcare Economist; 2013 [accessed 2015 Aug 26]. Available from http://healthcare-economist.com/2013/02/21/what-is-the-negative-binomial-model/.
- Morini E, Catalano A, Lasco A, et al. L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia. Endocrine. 2019;64(2):284–292.
- Benvenga S, Pantano R, Saraceno G, et al. A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of l-thyroxine, may have metabolic and cardiovascular consequences. J Clin Transl Endocrinol. 2019;16:100189.
- Scavone C, Sportiello L, Cimmaruta D, et al. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine. Minerva Endocrinol. 2016;41(2):279–289.